TG Therapeutics remains on track, with Q1 revenue matching my model and potential for 110% growth in 2025 if price increases hold. Analyst estimates for 2025 revenue have risen sharply, and Q2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback